论文信息 - How do state Medicaid programs determine what substance use disorder treatment medications need prior authorization? An overview for clinicians - 字舞流文

How do state Medicaid programs determine what substance use disorder treatment medications need prior authorization? An overview for clinicians

[1] Daniel M. Hartung,et al. Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018 , 2019, JAMA.

[2] P. Friedmann,et al. Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs , 2019, American journal of public health.

[3] B. Andraka-Christou,et al. A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices. , 2018, The International journal on drug policy.

[4] B. Tofighi,et al. Buprenorphine prescribing practice trends and attitudes among New York providers. , 2017, Journal of substance abuse treatment.

[5] C. Peters. The Medicaid Drug Rebate Program , 2009 .

[6] Hhs Centers for Medicare Medicare Services. Medicaid program; time limitation on recordkeeping requirements under the drug rebate program. Final rule. , 2004, Federal register.

[7] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..